Highlights New permanent Category I CPT code 75577 for AI-enabled coronary plaque analysis took effect January 1, 2026Major payers, including ...

Holy Cross Medical Center is expanding heart care for northern New Mexico residents with the introduction of HeartFlow Plaque ...

Elucid today announced that, effective January 1, 2026, its Plaque-IQ(TM) coronary plaque analysis has received a new Category I Current Procedural Terminology (CPT(R)) designation, alongside ...

Please provide your email address to receive an email when new articles are posted on . Alirocumab plus high-intensity statin therapy improved coronary plaque burden in patients with familial ...

Which patients with a history of myocardial infarction (MI) are at risk of having another? The tools to predict risk for recurrent cardiac events in patients with established coronary artery disease ...

November 9, 2009 (Boston, Massachusetts) — Harvard researchers present a reliable noninvasive approach for measuring coronary plaque progression with CT in a paper appearing in the November 2009 issue ...

The LoDoCo2 trial found a reduced cardiovascular risk with low-dose colchicine in patients with chronic coronary disease. In this substudy, attenuation of pericoronary adipose tissue did not differ ...

Please provide your email address to receive an email when new articles are posted on . The virus that causes COVID-19 may expedite progression of coronary lesions to high-risk plaque. SARS-CoV-2 was ...

Arterial blockage is one of the most serious threats to cardiovascular health in the United States. Recognizing its early ...

Equipped with knowledge of their coronary artery calcium (CAC) scan results and a statin prescription, patients were more likely to slow their plaque progression over 3 years. The trial studied people ...